- August 21, 2024
Macy’s misses on Q2 sales as it opts to double down on new strategy over buyout deal
Macy’s (M) is reporting another quarter of declining sales, a month after turning down a $6.9 billion buyout offer. On Wednesday, Macy’s reported a 3.8%
2 Unstoppable Healthcare Stocks to Buy Right Now With Less Than $200
The stock market remains one of the best ways to grow capital over time. And although having millions in the bank might help, a more
Bill Ackman’s Pershing Square Bought This Dow Laggard, Sold These Stocks| Investor’s Business Daily
Bill Ackman’s Pershing Square bought Nike (NKE) and Brookfield (BN) for the first time in the second quarter, a filing showed late Wednesday. Nike stock
Bitcoin Miner Marathon to Sell Notes to Buy More Bitcoin
(Bloomberg) — Bitcoin miner Marathon Digital Holdings Inc. said it will sell $250 million of convertible senior notes and use the proceeds to buy more
Nikola Doubles Truck Deliveries In Q2, Stock Soars
Nikola Doubles Truck Deliveries In Q2, Stock Soars Nikola Corp (NASDAQ:NKLA) stock gained after the company reported its fiscal second quarter 2024 results on Friday.
Wall Street sees ‘buying opportunity’ amid AI pullback
Artificial intelligence stocks, a hallmark of the recent bull market run, have lost steam over the past month. Nvidia (NVDA), Microsoft (MSFT), Alphabet (GOOGL,GOOG), and
Invest $25,000 in This Ultimate Dividend Growth Stock and Get $1,000 in Passive Income
It seems like everyone around you is telling you to invest in real estate. A barrage of influencer content constantly hits the media platforms telling
Nvidia stock soars 10% after strong AMD results, bullish call from Morgan Stanley
Nvidia (NVDA) stock rallied more than 10% on Wednesday following better than expected guidance from peer AMD (AMD) and a bullish call from analysts at
Why the Fed’s first rate cut wouldn’t be that big of a deal
A version of this post first appeared on TKer.co The calls for the Federal Reserve to begin cutting interest rates sooner than later have been
AbbVie Stock Jumps As Its New Golden Goose Looks To Overtake Humira
AbbVie (ABBV) stock reversed higher Thursday on a strong second-quarter showing from immunology drugs Skyrizi and Rinvoq, though earnings missed some Street projections. ↑ X
